Search Results - "SHAFI, Tariq"

Assessment of glycemia in chronic kidney disease by Hassanein, Mohamed, Shafi, Tariq

“…Reliable assessment of glycemia is central to the management of diabetes. The kidneys play a vital role in maintaining glucose homeostasis through glucose…”
Get full text

Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients by Shafi, Tariq, Powe, Neil R, Meyer, Timothy W, Hwang, Seungyoung, Hai, Xin, Melamed, Michal L, Banerjee, Tanushree, Coresh, Josef, Hostetter, Thomas H

“…Cardiovascular disease causes over 50% of the deaths in dialysis patients, and the risk of death is higher in white than in black patients. The underlying…”
Get full text

Vascular Access Type, Inflammatory Markers, and Mortality in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study by Banerjee, Tanushree, PhD, Kim, S. Joseph, MD, PhD, Astor, Brad, PhD, Shafi, Tariq, MBBS, MHS, Coresh, Josef, MD, PhD, Powe, Neil R., MD

“…Background Few reports have shown an association between access type and inflammatory marker levels in a longitudinal cohort. We investigated the role of…”
Get full text

Citation pattern of open access and toll-based research articles in the field of biological and physical sciences: a comparative study by Wani, Zahid Ashraf, Shah, Tariq Shafi

“…PurposeThe purpose of this paper is to determine the relationship between the access mode of research articles [Open Access (OA) and Toll-Access (TA)] and…”
Get full text

Novel Markers of Kidney Function as Predictors of ESRD, Cardiovascular Disease, and Mortality in the General Population by Astor, Brad C., PhD, Shafi, Tariq, MD, Hoogeveen, Ron C., PhD, Matsushita, Kunihiro, MD, Ballantyne, Christie M., MD, Inker, Lesley A., MD, Coresh, Josef, MD, PhD

“…Background Cystatin C level predicts mortality more strongly than serum creatinine level. It is unknown whether this advantage extends to other outcomes, such…”
Get full text

GFR Estimation Using β-Trace Protein and β2 -Microglobulin in CKD by Inker, Lesley A., MD, MS, Tighiouart, Hocine, MS, Coresh, Josef, MD, PhD, Foster, Meredith C., ScD, MPH, Anderson, Amanda H., PhD, Beck, Gerald J., PhD, Contreras, Gabriel, MD, Greene, Tom, PhD, Karger, Amy B., MD, PhD, Kusek, John W., PhD, Lash, James, MD, Lewis, Julia, MD, PhD, Schelling, Jeffrey R., MD, Navaneethan, Sankar D., MD, MPH, Sondheimer, James, MD, Shafi, Tariq, MBBS, MHS, Levey, Andrew S., MD

“…Background β-Trace protein (BTP) and β2 -microglobulin (B2M) are novel glomerular filtration markers that have stronger associations with adverse outcomes than…”
Get full text

Evaluation of a large-scale aptamer proteomics platform among patients with kidney failure on dialysis by Ren, Yue, Ruan, Peifeng, Segal, Mark, Dobre, Mirela, Schelling, Jeffrey R, Banerjee, Upasana, Shafi, Tariq, Ganz, Peter, Dubin, Ruth F

“…Patients with kidney failure suffer high mortality, and we currently lack markers for risk stratification for these patients. We carried out a quality control…”
Get full text

Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study by Jang, Hye Ryoun, Kang, Danbee, Sinn, Dong Hyun, Gu, Seonhye, Cho, Soo Jin, Lee, Jung Eun, Huh, Wooseong, Paik, Seung Woon, Ryu, Seungho, Chang, Yoosoo, Shafi, Tariq, Lazo, Mariana, Guallar, Eliseo, Cho, Juhee, Gwak, Geum-Youn

“…This study aimed to investigate the association of nonalcoholic fatty liver disease (NAFLD) and its severity with the decline in kidney function in patients…”
Get full text

Plasma metabolites and physical function in patients undergoing hemodialysis by Moorthi, Ranjani N., Moe, Sharon M., O’Connell, Thomas, Dickinson, Stephanie, Kalim, Sahir, Thadhani, Ravi, Clish, Clary B., Shafi, Tariq, Rhee, Eugene P., Avin, Keith G.

“…Impaired physical function contributes to falls, fractures, and mortality among patients undergoing dialysis. Using a metabolomic approach, we identified…”
Get full text

Association of Residual Urine Output With Mortality, Quality of Life, and Inflammation in Incident Hemodialysis Patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study by Shafi, Tariq, MBBS, MHS, Jaar, Bernard G., MD, MPH, Plantinga, Laura C., ScM, Fink, Nancy E., MPH, Sadler, John H., MD, Parekh, Rulan S., MD, MS, Powe, Neil R., MD, MPH, MBA, Coresh, Josef, MD, MHS, PhD

“…Background Residual kidney function (RKF) is associated with improved survival in peritoneal dialysis patients, but its role in hemodialysis patients is less…”
Get full text

Protein carbamylation and chronic kidney disease progression in the Chronic Renal Insufficiency Cohort Study by Kalim, Sahir, Berg, Anders H, Karumanchi, Subbian Ananth, Thadhani, Ravi, Allegretti, Andrew S, Nigwekar, Sagar, Zhao, Sophia, Srivastava, Anand, Raj, Dominic, Deo, Rajat, Frydrych, Anne, Chen, Jing, Sondheimer, James, Shafi, Tariq, Weir, Matthew, Lash, James P

“…Abstract Background Protein carbamylation is a post-translational protein modification caused, in part, by exposure to urea’s dissociation product cyanate…”
Get full text

Free Levels of Selected Organic Solutes and Cardiovascular Morbidity and Mortality in Hemodialysis Patients: Results from the Retained Organic Solutes and Clinical Outcomes (ROSCO) Investigators by Shafi, Tariq, Meyer, Timothy W, Hostetter, Thomas H, Melamed, Michal L, Parekh, Rulan S, Hwang, Seungyoung, Banerjee, Tanushree, Coresh, Josef, Powe, Neil R

“…Numerous substances accumulate in the body in uremia but those contributing to cardiovascular morbidity and mortality in dialysis patients are still undefined…”
Get full text

Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study by Grams, Morgan E., MD, PhD, Yang, Wei, PhD, Rebholz, Casey M., PhD, MS, MPH, Wang, Xue, MS, Porter, Anna C., MD, Inker, Lesley A., MD, MS, Horwitz, Edward, MD, Sondheimer, James H., MD, Hamm, L. Lee, MD, He, Jiang, MD, PhD, Weir, Matthew R., MD, Jaar, Bernard G., MD, MPH, Shafi, Tariq, MBBS, MHS, Appel, Lawrence J., MD, MPH, Hsu, Chi-yuan, MD, MSc

“…Background People with advanced chronic kidney disease are at risk for the development of end-stage renal disease (ESRD), but also many other adverse outcomes,…”
Get full text

Hemodialysis Prescription for Incident Patients: Twice Seems Nice, But Is It Incremental? by Toth-Manikowski, Stephanie M., MD, Shafi, Tariq, MBBS, MHS

Get full text

Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES) by Kaczmarski, Katerina R, Sozio, Stephen M, Chen, Jingsha, Sang, Yingying, Shafi, Tariq

“…Apparent treatment-resistant hypertension (aTRH) is a common condition associated with risk of cardiovascular events. However, the risk of cardiovascular…”
Get full text

Author Correction: Nonalcoholic fatty liver disease accelerates kidney function decline in patients with chronic kidney disease: a cohort study by Jang, Hye Ryoun, Kang, Danbee, Sinn, Dong Hyun, Gu, Seonhye, Cho, Soo Jin, Lee, Jung Eun, Huh, Wooseong, Paik, Seung Woon, Ryu, Seungho, Chang, Yoosoo, Shafi, Tariq, Lazo, Mariana, Guallar, Eliseo, Cho, Juhee, Gwak, Geum-Youn

“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text

Serum Fructosamine and Glycated Albumin and Risk of Mortality and Clinical Outcomes in Hemodialysis Patients by SHAFI, Tariq, SOZIO, Stephen M, PLANTINGA, Laura C, JAAR, Bernard G, KIM, Edward T, PAREKH, Rulan S, STEFFES, Michael W, POWE, Neil R, CORESH, Josef, SELVIN, Elizabeth

“…Assays for serum total glycated proteins (fructosamine) and the more specific glycated albumin may be useful indicators of hyperglycemia in dialysis patients,…”
Get full text

Autonomic dysfunction as a mechanism of intradialytic blood pressure instability by Shafi, Tariq, Mullangi, Surekha, Jaar, Bernard G., Silber, Harry

“…The autonomic nervous system (ANS) is the principal endogenous defense mechanism that maintains blood pressure in the setting of hypotension. Disruption of the…”
Get full text

Association of Intradialytic Blood Pressure Variability With Increased All-Cause and Cardiovascular Mortality in Patients Treated With Long-term Hemodialysis by Flythe, Jennifer E., MD, Inrig, Jula K., MD, MHS, Shafi, Tariq, MBBS, MHS, Chang, Tara I., MD, MS, Cape, Kathryn, MPH, Dinesh, Kumar, MD, Kunaparaju, Shrikanth, MD, Brunelli, Steven M., MD, MSCE

“…Background Blood pressure is known to fluctuate widely during hemodialysis; however, little is known about the association between intradialytic blood pressure…”
Get full text

Serum Asymmetric and Symmetric Dimethylarginine and Morbidity and Mortality in Hemodialysis Patients by Shafi, Tariq, MBBS, MHS, Hostetter, Thomas H., MD, Meyer, Timothy W., MD, Hwang, Seungyoung, MS, MSE, Hai, Xin, PhD, Melamed, Michal L., MD, MHS, Banerjee, Tanushree, PhD, Coresh, Josef, MD, PhD, Powe, Neil R., MD, MPH, MBA

“…Background Asymmetric (ADMA) and symmetric dimethylarginine (SDMA) are putative uremic toxins that may exert toxicity by a number of mechanisms, including…”
Get full text